杨巍;梅育嘉;

• 1:广西南宁市红十字会医院心内科

摘要(Abstract)：

慢性心力衰竭(CHF)是各种心血管疾病发展的最后阶段,成为影响公众健康、危害患者生存质量的主要因素。近年来,国内外对于CHF的诊治有了很大进展,特别是CHF的治疗从过去的改善血液动力学转变为更着重于改善和逆转心脏重塑。笔者对此阶段研究及干细胞移植要点进行介绍。

关键词(KeyWords)： 慢性心力衰竭;诊断;治疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 杨巍;梅育嘉;

Email:

DOI:

参考文献(References)：

• [1]Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA2005Guideline Update for the Diagnosis and Management of Chro-nic Heart Failure in the Adult:a report of the American Col-lege of Cardiology/American Heart Association Task Force on Practice Guidelines[J].Circulation,2005,112:e154-235.
• [2]晓熠.2008《心力衰竭预防共识》节选[N].中国医学论坛报2008,5(15):C08.
• [3]黄峻.血管紧张素受体阻滞剂在慢性心力衰竭治疗中的重要作用[J].中华心血管病杂志,2006,34(9):773-774.
• [4]American Heart Association.Heart disease and stroke statistics-2006update[M].Dallas Tex American Heart Association2006:25-26.
• [5]戴闺柱.2005年美国慢性收缩性心力衰竭治疗指南浅析[J].中华心血管病杂志,2005,33(12):1065-1066.
• [6]Vuolteenaho O,Ala-Kopsals M,Ruskoaho H,et al.BNP as a biomarker in heart disease[J].Adv Clin Chen,2005,40:1-36.
• [7]金兰.慢性心力衰竭的药物治疗[J].中国实用内科杂志,2004,24(1):13-15.
• [8]Hunt SA,Bachi DW,Chin MH,et al.ACC/AHA guideline for the evaluation and management of chronic heart failure in the adult:executive summary[J].J Am Coll.Cardio1,2006,38:2100-2113.
• [9]Swedberg K,Cleland J,Dargie H,et al.Guidelines for the di-agnosis and treatment of chronic heart failure executive sum-mary(update2005):The task force for the diagnosis and treatment of chronic heart failure of the European society of cardiology[J].Eur Heart J,2005,26:1115-1140.
• [10]American Heart Association Heat disease and stroke statistics-2006update[M].Dallas Tex American Heart Association2006,10:25-26.
• [11]吴学思.正确掌握β受体阻滞剂在慢性心力衰竭的应用时机[J].中华心血管病杂志,2006,34(9):769-771.
• [12]Hjalmarson A,Coldstein S,Fagerberg B,et al.Effects of con-trolled-release metoprolol on total mortality,hospitalizations and well-being in patients with heart failure:the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure(MERIT-HF).MERIT-HF Study Group[J].JAMA,2006,283:1295-1302.
• [13]Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol onsurvive-al in severe chronic heart failure[J].N Engl J Med,2005,344:1651-1658.
• [14]Poole-Wilson PA,Swedberg K,Cleland JG,et al.Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol Eu-ropean Trial(COMET):random isled controlled trial[J].Lancet,2003,362:7-13.
• [15]Willenheimer R,Van Veldhuisen DJ,Silke B,et al.Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril as compared with the opposite sequence results of the randomized Cardiac Insufficiency Bisoprolol Study(CIBIS)Ⅲ[J].Circulation,2005,112:2426-2435.
• [16]Sliwa K,Norton GR,Kone N,et al.Impact of initiating carve-dilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure[J].J Am Cardio1,2004,44:1825-1830.
• [17]Pitt B,Zannad F,Remme WJ,et al.The effect of spironolac-ton on mobility and mortality in patients with severe heart fail-ure[J].N Engl J Med,2006,341(10):709-717.
• [18]He Z,Way KJ,Arikawa E,et al.Differential regulation of an-giotensinⅡ-induced expression of connective tissue growth factor by protein kinas C is forms in the myocardium[J].Biol Chem,2005,280(16):15719-15726.
• [19]Rocha R,Williams CH.Rationale for the use of aldosterone antagonists in congestive heart failure[J].Drugs,2002,62(5):723-731.
• [20]鲁燕,冯燕光,王卉茜,等.螺内酯治疗心力衰竭的价值[J].临床荟萃,2006,21(13):930-932.
• [21]Elkayam U,Akhter MW,Singh H,et al.Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensate heart failure[J].Am J Cardio1,2004,93:237-240.
• [22]Moss AJ,Zareba W,Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and re-duced ejection fraction[J].N Engl J Med,2002,346:877-883.
• [23]Bristow MR,Saxon LA,Boehmer J.Cardiac-resynchronization therapy with or without an implant table defibrillator in ad-vanced chronic heart failure[J].N Eng1J Med,2004,350:2140-2150.
• [24]Smits PC,Van Geuns RJ,Poldemans D,et al.Catheter-based intramyocardial injection of antilogous skeletal my oblasts as a primary treatment of ischemic heart failure clinical experience with six-month follow-up[J].J Am Coll Cardiol,2003,42(12):2063-2069.
• [25]Gao LR,Wang ZG,Zhu ZM,et al.Effect of intracoronary transplant-ration of antilogous bone marrow-derived mononu-clear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy[J].Am J Cardio1,2006,98(5):597-602.
• [26]吴朝晖,袁明远,劳汉珠,等.自体外周血干细胞移植治疗扩张型心肌病[J].中国医药,2006,1(1):11-13.